On December 20, Petrovax Pharm completed supplies of the
Petrovax Pharm started shipping the vaccine in November immediately after winning the bidding invited by the Russian Ministry of Health. Within the shortest time possible, the vaccine was delivered to all Russia’s regions.
Petrovax Pharm is the first Russian company to perform a
Pneumococcal infection: background information
Pneumococcal infection is a pressing issue for Russia’s public health because of high prevalence, severity, and a high disability and mortality risk. According to the Russian Ministry of Health, pneumococcus ranks first among the pneumonia, meningitis, and bacterial otitis causes in children from birth until the age of 5 years. It also leads the ranks in terms of lethality rate in infants. In Russia, pneumococcal vaccination has been on the National Immunization Schedule since 2014.